Nektar Therapeutics
NKTR
NKTR
342 hedge funds and large institutions have $5.41B invested in Nektar Therapeutics in 2018 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 138 increasing their positions, 122 reducing their positions, and 91 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
342
Holders Change
-45
Holders Change %
-11.63%
% of All Funds
7.63%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
50
Increased
138
Reduced
122
Closed
91
Calls
$89.9M
Puts
$50.5M
Net Calls
+$39.4M
Net Calls Change
-$30.3M
Top Buyers
| 1 |
O
OppenheimerFunds
New York
|
+$174M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$99.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$67.1M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$24M |
| 5 |
D.E. Shaw & Co
New York
|
+$20.6M |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$67.8M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$66M |
| 3 |
Millennium Management
New York
|
-$51.7M |
| 4 |
Capital Fund Management (CFM)
Paris,
France
|
-$43.1M |
| 5 |
SI
Scout Investments
Kansas City,
Missouri
|
-$28.9M |
